Newsroom

Industry News

26 May

NAC Receives Production Contract for Precision Surveillance System Drives

NAC Global Technologies (OTCQB: NACG) announced today it has received a production contract to supply its Harmonic Gearing Technology (HGT) to a market-leading manufacturer of advanced surveillance and security systems. Having completed a 4-month testing and validation process, NAC’s SHF series drives are adopted for precise motion control of the...

Read more

26 May

Calpian to Present at the 2015 Marcum Microcap Conference

Calpian, Inc. (CLPI), an innovative global mobile payments technology and processing company announced today that it will present at the 2015 Marcum MicroCap Conference on Thursday, May 28, 2015 in New York City at the Grand Hyatt Hotel. Calpian’s presentation by Harold Montgomery, CEO, is scheduled to begin at...

Read more

26 May

Attitude Drinks Incorporated Completes Major Restructuring of Financial Position and Operations

Attitude Drinks Incorporated (the “Company”) (OTC PINK: ATTD), an innovative and opportunistic beverage brand development company, announced today that it has completed a major restructuring of the Company’s balance sheet which has eliminated approximately $6.4 million of principal, accrued interest and penalties on outstanding Company Notes (“Debt”) by exchanging the...

Read more

26 May

Matinas BioPharma to Present at the Fourth Annual SeeThru Equity Microcap Investor Conference on May 28, 2015

- Presentation With Audio Webcast at 11:30 a.m. EDT - Matinas BioPharma Holdings, Inc. (“Matinas BioPharma” or the “Company”) (MTNB), a clinical-stage biopharmaceutical company principally focused on the development of lipid-based prescription therapeutics for the treatment of infectious diseases, today announced that it will be presenting at the Fourth Annual...

Read more

26 May

FDA Grants Fast Track Designation for Intellipharmaceutics Rexista(TM) Oxycodone XR Incorporating PODRAS(TM) Technology

Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the United States Food and Drug Administration (“FDA”) has reviewed the Company’s request for Fast Track...

Read more

26 May

Inovio to Present at Jefferies Healthcare Conference

Inovio Pharmaceuticals, Inc. (INO) announced today that Dr. J. Joseph Kim, President and CEO, will give a corporate presentation at the Jefferies 2015 Healthcare Conference on Thursday, June 4 at 8:30 AM ET. A live and archived version of Dr. Kim’s presentation will be made available through the “Webcast”...

Read more

22 May

InspireMD’s CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference

PARADIGM Evaluation Reports CGuardTM Favorable Outcomes in All-Comer Carotid Disease Population  InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in stent embolic protection systems (“EPS”), today announced that its CGuardTM Embolic Prevention System reported positive results in PARADIGM, lead by principle investigator Prof. Piotr Musialek, at...

Read more

22 May

Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology

Statistically Significant Findings Identify Key Efficacy Targets for Phase IIb/III Clinical Trial with RGN-259  RegeneRx Biopharmaceuticals, Inc. (RGRX)(“the Company” or “RegeneRx”) today announced a peer-reviewed publication of the results of the Company’s 72-patient, placebo-controlled Phase II study evaluating RGN-259 (RegeneRx’s preservative-free eye drops) for the treatment of dry eye...

Read more

Page 1 of 7212345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets